General Sales & Leasing Inc. (GSL), Xenetic Biosciences deal

GSL made a non-binding offer to acquire the share capital of Xenetic Biosciences. Xenetic's ErepoXen is a long-acting erythropoietin (EPO) in Phase II testing for anemia in chronic kidney disease (CK...